Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
RECRUITING
NCT03708627
EARLY_PHASE1
Bimatoprost as a Treatment for Graves' Orbitopathy
Sponsor: Johns Hopkins University
View on ClinicalTrials.gov
Summary
Testing whether Bimatoprost, a topical eye drop used for glaucoma, can be used to induce periorbital fat atrophy in patients with Graves' disease
Official title: The Role of Bimatoprost in Graves' Periorbitopathy
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
3
Start Date
2017-11-01
Completion Date
2031-07-01
Last Updated
2025-07-17
Healthy Volunteers
No
Conditions
Interventions
DRUG
Bimatoprost Ophthalmic
Bimatoprost, aka Lumigan, one drop in one eye nightly
Locations (1)
University of Washington
Seattle, Washington, United States